A Phase 3 trial of CNTX-4975 for the treatment of chronic moderate to severe knee osteoarthritis

Trial Profile

A Phase 3 trial of CNTX-4975 for the treatment of chronic moderate to severe knee osteoarthritis

Planning
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs Capsaicin (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jun 2017 New trial record
    • 13 Jun 2017 According to a Centrexion Therapeutics media release, based on the positive data from Phase IIb trial (see profile 261253) and the successful End of Phase 2 meetings with the FDA and the European authorities, the company is planning to start this trial later in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top